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Introduction
Multiple sclerosis (MS) is one of the most common
demyelinating diseases of the central nerves system (1). This
disease is classified to three groups such as Relapsing
Remitting Multiple Sclerosis (RRMS), Secondary
Progressive Multiple Sclerosis (SPMS), Primary
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Progressive Multiple Sclerosis (PPMS) based on the onset
and progression of the disease. In the recent past, it has
been noticed that there is a gradual increase in the incidence
of multiple sclerosis in the world's population. Iran found
to have maximum number of MS patients in the Persian
Gulf. According to the latest statistics, there are about 70000
cases of MS in a population of 81 million (2). The exact
aetiology is unknown. But the following factors such as
genetic abnormality, autoimmunity and various
environmental factors are incriminated in the
aetiopathogenesis of this disease. in addition, factors like
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ABSTRACT
Introduction: Multiple sclerosis is one of the most common demyelinating diseases of the central nerves system.
It runs in families. The aim of this study is to investigate the prevalence of familial multiple sclerosis in Ardabil province in
Iran.
Methods: A cross-sectional study was performed on 611 patients of multiple sclerosis, who were registered in
Ardabil MS registry system in Alavi hospital of Ardabil Province in Iran. The necessary data with the respect of positive
family history of multiple sclerosis (MS), and other relevant information was collected and analyzed by statistical method in
SPSS Version 19. The p- value of <0.05 was considered as significant value.
Results: In our study of 611 patients, female preponderance was noticed and the male to female ratio was 1:
2.57.In this study only 85 patients (14%) gave positive family history of MS. When compared to the available data, this
positive family history of MS was low in Ardabil Province in Iran.
Conclusion: The incidence of positive family history of MS was low in Ardabil Province when compared to the
incidence in other provinces of Iran.
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sex, age,   the geographical location and the local racial
characteristics may also play a role in the aetiopathogenesis
of MS (3). MS is generally more common in the areas away
from the equator, especially at a latitude of 40 degrees North
and South (4)..Studies showed that MS is seen in all races
but the increased prevalence is reported among north
European races (5, 6). The prevalence of familial MS is
higher than in general population in certain geographical
locations (7, 8, 9, 10, and 11). The aim of this study is to
investigate the prevalence of familial multiple sclerosis in
Ardabil province of Iran.
Methods
This cross-sectional study was performed from the
beginning of the January 2017 to December of 2018.  611
patients were selected from the Ardabil MS Registry. . The
presence of disease was confirmed based on McDonald
Criteria by the trained neurologist. The Data collected
included demographic and clinical information of all the
patients such as sex, age, presence of familial history, area
of residence signs and symptoms of the disease. The
collected data was analyzed by using SPSS version 19. The
p value of <0.05 was considered significant.
Results
The total number of patients was 611. Out of which the
females were found to be 440 (72%) and male were found
to be 171 (28%). The male to female ratio was found to be
1:2.57. However the incidence of familial MS was found to
be 85. Male patient were found to be 23 amongst the total
number of 171 patients (13.5%). The female patients were
42 amongst the total number of 440 (14.1%)
The mean age of patients with familial MS was
found to be 36.1 +/- 9.5 years and without familial history
was found to be 35.1+/- 9.3 years. Statistically the difference
between familial and non familial MS was not significant.
Out of total 611 patients 81 patients had some co
morbid conditions (13.3%), such as diabetes mellitus,
cardiac diseases etc. However amongst familiar MS patients
of 85, 17 patients had some co morbid condition (21%),
which is statistically significant.
Similarly the signs and symptoms among the familial
MS vary from the patients of non familial MS. For example
optic neuritis was found to be 17.5% in total number of MS
patients, but in familial MS patients it was found to be only
10.3%. Diplopia was found to be 12.9% in total number of
patients of 611, whereas in familial MS it was found to be
15.2%. Cerebral disorders were found to be 10% in non
familial MS patients and 13.1% in familial MS patients.
Motor disorders was found to be 20.6% in non familial MS
patients and 13.3% in familial MS patients (Table.1).
Table1.Relationship between prevalence of FMS and patient
characteristics
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Discussion
There has been a gradual increase in the incidence
of multiple sclerosis in the world population in the recent
past. However the incidence was found to be low in Iran.
However the incidence of familial MS was found to be more
in Iran when compared to other countries. This study was
armed to compare the incidence of familial MS in Ardabil
province when compared to the other province of Iran.
Out study revealed the ratio of familial MS to general
incidence was found to be 1:72 which was almost similar to
other provinces in Iran, like East Azerbaijan rate of 7.1,
Zanjan with 7.3 and Mazandaran with 7 (12,13,14). In
addition the pooled prevalence rate of familial MS was about
11% for Iran but our study revealed the prevalence rate of
approximately 13.9% which was higher (15). Nielsen et al
utilized a nationwide registry data and reported that risk of
MS in familial with a positive history of MS was seven
times more than normal population (16). In a study in Jordon,
the prevalence of family history of MS reported to be 9.4%
(17). In another study with 35 years follow up, it has been
identified a high familial rate, almost 32.7% suggesting as
genetic susceptibility (18). Familial   MS was found to be
more common among first and third degree relatives as per
a study by Toghaianifar et al in Isfahan (19). Nielsen et al
reported that the first degree relatives have 2.5% excess
risk irrespective of their gender (16). Carton et al also
reported 10-12 fold increased risk of MS for second degree
relatives in their observed population (20).
Population based studies have shown that the
recurrence rate of MS ranged from 20% to 30% in
monozygotic twins and 5% in dizygotic twins (21). Although
MS is higher in women in the general population, in the
same study it was not revealed so. However, in a study in
Isfahan province of Iran in 2014 in familial MS male to
female ratio was 1:2.6(19). The study in Khuzestan province
of Iran also revealed that positive family history of MS was
significantly higher among men, but there was not much of
difference in the general population (22) As far as age of
the familial MS patients was concerned, a study in Isfahan
province of Iran found out nor much of a difference between
familial and non familial MS patients (23). However, a study
in Spain found that familial MS presented about 8 years
sooner than non  familial MS (22years vs. 30 years) (24). In
another study of PPMS patients, familial PPMS patients
were found to be significantly younger at the onset of disease
(n= 84, median age: 37.6 years) than patients, sporadic
disease (n= 327, median age: 42.7 (25).
The most common symptoms among patients with
FMS were motor symptoms and diplopia
approximately16.7%and 15.2% respectively in our study.
However in the Toghaianifar et al study, sensory symptoms
and visual symptoms were common with the incidence of
40.7% and 27.7% respectively (19). In yet another study of
Akbari et al, optic neuritis and sensory symptom was
common with the incidence of 3.6% and 30.3 % respectively
(26).
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Conclusion
 Our results showed that familial MS in Ardabil province
of Iran is lower than other provinces in Iran. The incidence
of female patients is more than male population in FMS,
when compared to non familial MS. It is recommended to
do non studies to do more studies to know genetic and
environmental factors in the aetiology of familial MS.
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